Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-24-000706)

Filing Details

Accession Number:: 0001683168-24-000706
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-06 10:27:39
Reporting Period:: 2024-02-01

Accepted Time:: 2024-02-06 10:27:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1729427	Cns Pharmaceuticals Inc.	CNSP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705978	Christopher Downs	C/O Cns Pharmaceuticals, Inc. 2100 West Loop South, Suite 900 Houston TX 77027	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-02-01	66,666	$0.30	103,438	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrant to purchase common stock	Acquisiton	2024-02-01	66,666	$0.00	66,666	$0.30
Common Stock	Series B Warrant to purchase common stock	Acquisiton	2024-02-01	66,666	$0.00	66,666	$0.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
94,906	2024-02-01	2029-02-01	No	4	A	Direct
161,572	2024-02-01	2025-10-01	No	4	A	Direct

Footnotes

The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.